Cargando…

What happens after hepatitis C eradication?

Detalles Bibliográficos
Autor principal:	Pol, Stanislas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Invited Speaker Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360401/ http://dx.doi.org/10.1186/1742-4690-9-S1-I19

Ejemplares similares

Research and development for the malaria elimination/eradication roadmap
por: Tanner, Marcel, et al.
Publicado: (2010)

New medicines to improve control and contribute to the eradication of malaria
por: Wells, Timothy NC
Publicado: (2010)

Molecular mechanisms involved in HIV latency and implications for HIV treatment and eradication
por: Alcami, Jose, et al.
Publicado: (2010)

Hepatitis C as a metabolic disease
por: Andre, Patrice
Publicado: (2012)

Plasmodium ovale sp. and Plasmodium malariae in Africa: difficult items of business on the malaria eradication agenda
por: Sutherland, Colin J, et al.
Publicado: (2010)

Immunotherapy of food allergy: what is effective?
por: Renz, Harald
Publicado: (2011)

What has changed in the diagnostic approach?
por: Fiocchi, Alessandro
Publicado: (2011)

Immunotherapy of food allergy: what is effective?
por: Sampson, Hugh
Publicado: (2011)

What is new in the treatment of eosinophilic eosophagitis?
por: Assa'ad, Amal
Publicado: (2011)

Migraine and epilepsy: what value today?
por: Costa, Cinzia, et al.
Publicado: (2015)

What makes an antigen a food allergen?
por: Mills, Clare
Publicado: (2011)

Hepatitis E: state of the art
por: Dalton, Harry
Publicado: (2010)

Hepatitis B: treatment strategies and resistance
por: Soriano, Vincent
Publicado: (2010)

Transgenic biotechnology in forestry: what a long strange trip it's been
por: Strauss, Steven H
Publicado: (2011)

What does it take to be healthy? Investigating immune-deficiency in non-immunodeficient scenarios
por: Binda, Elisa, et al.
Publicado: (2012)

PReS13-SPK-1322: Autoinflammatory in nature: what patients teach us
por: Gattorno, M
Publicado: (2013)

Hydrocephalus treatment and outcome in African infants with myelomeningocele: what we have learned so far
por: Warf, Benjamin C
Publicado: (2010)

PReS13-SPK-1182: Six years of eu paediatric regulation - what was achieved for paediatric rheumatology
por: Vesely, R
Publicado: (2013)

INSP-01. What to do when you cannot randomize? Leveraging Historical Data in Efficient Study Designs for Pediatric Neuro-Oncology.
por: Onar-Thomas, Arzu
Publicado: (2022)

Biochemical and virological analysis of the preference for the K65R multi-resistance nucleoside mutation in subtype C viruses
por: Wainberg, Mark A, et al.
Publicado: (2009)

Treatment of hepatitis C in HIV patients in the new DAA era
por: Soriano, Vicente
Publicado: (2014)

Hepatitis E
por: Dalton, Harry
Publicado: (2014)

INSP-06. Recent advances in improving neuropsychological outcomes for paediatric brain tumour patients - Are we entering a new era?
por: Mabbott, Donald
Publicado: (2022)

INSP-09. Using genetically engineered mouse models and patient-derived orthotopic xenografts to develop new therapies for pediatric brain tumors.
por: Jonchere, Barbara, et al.
Publicado: (2022)

INSP-04. Confirmatory adaptive designs for survival trials with several time-to-event endpoints
por: Schmidt, Rene
Publicado: (2022)

INSP-08. Cerebellar mutism syndrome: incidence, symptoms, risk factors, prognosis. Results and future perspectives from the Nordic-European study of the cerebellar mutism syndrome
por: Sehested, Astrid, et al.
Publicado: (2022)

INSP-03. Neuronal regulation of glioma progression
por: Monje, Michelle
Publicado: (2022)

INSP-17. Augmented Drug Delivery for Pediatric Diffuse Midline Glioma using Convection Enhanced Delivery
por: Souweidane, Mark M
Publicado: (2022)

INSP-14. Novel approaches to molecular diagnostics
por: Sahm, Felix
Publicado: (2022)

INSP-07. Improving cognitive outcomes for children treated for cancer: moving beyond the cure
por: Conklin, Heather
Publicado: (2022)

INSP-02. WHO 2021 classification of CNS tumors
por: Wesseling, Pieter
Publicado: (2022)

INSP-16. Focused ultrasound-mediated blood-brain barrier disruption for the treatment of pediatric high-grade glioma
por: van Vuurden, Dannis, et al.
Publicado: (2022)

INSP-05. Development of fast cortical rhythms in health and mental disease
por: Hanganu-Opatz, Ileana
Publicado: (2022)

Involvement of the ocular system in hypohidrotic ectodermal dysplasia
por: Kaercher, Thomas
Publicado: (2012)

Antiretroviral generics
por: Andrieu, Véronique
Publicado: (2012)

New antiretrovirals
por: Gulick, Roy
Publicado: (2012)

Dermatologic aspects of ectodermal dysplasias
por: Itin, Peter H
Publicado: (2012)

How to keep a patient support group running?
por: Gomez, Karla Padilla, et al.
Publicado: (2012)

Molecular control of HIV - 1 postintegration latency: implications for therapeutic strategies
por: Van Lint, Carine
Publicado: (2012)

The long way from bench to bedside
por: Gaide, Olivier
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_qm2cge3adrqtqe44eifg4iekgk